Home › NDC Lookup › Labelers › Orient Pharma Co., Ltd.

Orient Pharma Co., Ltd. NDCs and Package Codes

This page lists NDC package records associated with labeler code 76333 (Orient Pharma Co., Ltd.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

5
Package NDCs
2
Products
2
Active listings
0
Discontinued
2
Ingredients
0
Therapeutic classes
2
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
TOFACITINIB 1
Ezetimibe 1
By dosage form
TABLET, FILM COATED, EXTENDED RELE... 1
TABLET 1

Browse records — 2 products

Drug / product Billing NDC NADAC / unit Status
Ezetimibe 10 mg/1 TABLET Orient · NDC 76333-0170-15 · 30 TABLET in 1 BOTTLE (76333-170-15) 76333-0170-15 — On market View →
TOFACITINIB 11 mg/1 TABLET, FILM COATED, EXTENDED RELEASE Orient · NDC 76333-0111-15 · 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (76333-111-15) 76333-0111-15 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.